Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
10/2011
10/27/2011US20110263656 Pirfenidone Treatment for Patients with Atypical Liver Function
10/27/2011US20110263654 Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid
10/27/2011US20110263648 Bridged tetrahydronaphthalene derivatives
10/27/2011US20110263644 Compounds and Methods for Treatment of Stroke
10/27/2011US20110263628 N-hydroxyamide derivatives and use thereof
10/27/2011US20110263623 Process for preparation of bosentan
10/27/2011US20110263619 Pharmaceutical formulations and use thereof in the prevention of stroke, diabetes and/or congestive heart failure
10/27/2011US20110263617 Combination therapy for the treatment of diabetes and related conditions
10/27/2011US20110263606 Solid oral dosage forms comprising tadalafil
10/27/2011US20110263600 Method for preventing or treating a disease related to the glucocorticoid receptor
10/27/2011US20110263595 Compounds and methods for kinase modulation, and indications therefor
10/27/2011US20110263594 Novel triazolo(4,3-a)pyridine derivatives, process for the preparation thereof, use thereof as medicaments, pharmaceutical compositions and novel use, in particular as met inhibitors
10/27/2011US20110263593 NOVEL IMIDAZO[1,2-a]PYRIMIDINE DERIVATIVES, METHOD FOR THE PREPARATION THEREOF, USE THEREOF AS MEDICAMENTS, PHARMACEUTICAL COMPOSITIONS AND NOVEL USE, IN PARTICULAR AS MET INHIBITORS
10/27/2011US20110263589 Method for preventing or treating a glucocorticoid receptor-related disease
10/27/2011US20110263583 Cyclic Inhibitors Of 11Beta-Hydroxysteroid Dehydrogenase 1
10/27/2011US20110263582 Cyclic urea inhibitors of 11 b-hydroxysteroid dehydrogenase 1
10/27/2011US20110263579 Chlorothiazide, chlorothiazide salts and pharmaceutical compositions thereof
10/27/2011US20110263578 Heteroaryl-cyclohexyl-tetraazabenzo[e]azulenes
10/27/2011US20110263577 Novel oxadiazolyl-diazabicyclononane derivatives and their medical use
10/27/2011US20110263575 Compounds Useful as Protein Kinase Inhibitors
10/27/2011US20110263573 Heterobiaryl-cyclohexyl-tetraazabenzo[e]azulenes
10/27/2011US20110263569 Ryanodine channel binders and uses thereof
10/27/2011US20110263568 Topical pharmaceutical composition comprising a cholinergic agent or a calcium channel blocker
10/27/2011US20110263567 Compounds for inhibiting semicarbazide-sensitive amine oxidase (ssao) / vascular adhesion protein-1 (vap-1) and uses thereof for treatment and prevention of diseases
10/27/2011US20110263562 Bicyclic compound
10/27/2011US20110263561 Novel pyrrolidone derivatives for use as MetAP-2 inhibitors
10/27/2011US20110263560 Organic Compounds
10/27/2011US20110263557 Compounds and compositions as modulators of gpr119 activity
10/27/2011US20110263555 TGR5 Modulators and Methods of Use Thereof
10/27/2011US20110263548 Pyridone and pyridazone analogues as gpr119 modulators
10/27/2011US20110263547 C-19 steroids for specific therapeutic uses
10/27/2011US20110263544 1-Phenylpyrrole Derivatives
10/27/2011US20110263533 Novel cyclic benzimidazole derivatives useful as anti-diabetic agents
10/27/2011US20110263526 Nitric Oxide Releasing Prodrugs of Therapeutic Agents
10/27/2011US20110263518 D-Tagatose-Based Compositions and Methods for Preventing and Treating Atherosclerosis, Metabolic Syndrome, and Symptoms Thereof
10/27/2011US20110263516 Vasodilator
10/27/2011US20110263506 Peptides having an ace inhibiting effect
10/27/2011US20110263505 Whey Protein Hydrolysate Containing Tryptophan Peptide Consisting of Alpha Lactalbumin and the Use Thereof
10/27/2011US20110263504 Tissue protective peptides and peptide analogs for preventing and treating diseases and disorders associated with tissue damage
10/27/2011US20110263497 Apo a-i mimetic peptides and methods of treatment
10/27/2011US20110263496 Exendins to lower cholesterol and triglycerides
10/27/2011US20110263494 Nonsteroidal compounds useful as modulators of glucocorticoid receptor ap-1 and/or nf-kappab acitivity and use thereof
10/27/2011US20110263483 Compositions and methods for treating pathologic angiogenesis and vascular permeability
10/27/2011US20110263027 Adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby
10/27/2011US20110262563 Compositions and methods for the prevention and treatment of cardiovascular diseases
10/27/2011US20110262555 Methods and compositions for reducing or preventing vascular calcification during peritoneal dialysis therapy
10/27/2011US20110262535 Low Dose Topiramate / Phentermine Composition and Methods of Use Thereof
10/27/2011US20110262534 polysaccharide capsule enclosing a fatty acid oil-containing emulsion
10/27/2011US20110262530 Sustained release of apo a-i mimetic peptides and methods of treatment
10/27/2011US20110262518 Treatment for cardiac injuries created by myocardial infarction
10/27/2011US20110262511 Novel Uses
10/27/2011US20110262490 Polymer-agent conjugates, particles, compositions, and related methods of use
10/27/2011US20110262485 Sting (stimulator of interferon genes), a regulator of innate immune responses
10/27/2011US20110262466 Compositions containing thrombomodulin domains and uses thereof
10/27/2011US20110262456 Method of treating ischemia reperfusion injury
10/27/2011US20110262449 Method for the treatment of gout or pseudogout
10/27/2011US20110262445 Anti-il-12/il-23 antibodies
10/27/2011US20110262438 Biological materials related to cxcr7
10/27/2011US20110262432 mutated netrin 4 proteins, fragments thereof and their uses as drugs
10/27/2011US20110262429 Human timp-1 antibodies
10/27/2011US20110262419 Specifically targeted catalytic antagonists and uses thereof
10/27/2011US20110262407 Treatment with alpha7 selective ligands
10/27/2011US20110262398 Cardiac treatment using anti-fibrotic agents
10/27/2011US20110262388 Novel inhibitors
10/27/2011US20110262386 Methods of treating inflammation
10/27/2011US20110262379 Maleamic Acid Polymer Derivatives and Their Bioconjugates
10/27/2011US20110262374 Novel compound ramalin and use thereof
10/27/2011CA2796710A1 Valsartan derivatives carrying nitrogen oxide donors for the treatment of vascular and metabolic diseases
10/27/2011CA2796637A1 Certain amino-pyrimidines, compositions thereof, and methods for their use
10/27/2011CA2792950A1 5-(optionally substituted phenyl) pyridin-2-yl compounds as metalloenzyme inhibitors
10/27/2011CA2727957A1 Pharmaceutical composition comprising levamlodipine and indapamide
10/26/2011EP2380971A2 Perivascular mesenchymal precursor cells
10/26/2011EP2380969A2 Perivascular mesenchymal precursor cell induced blood vessel formation
10/26/2011EP2380884A1 Carboxylic acid derivative containing thiazole ring and pharmaceutical use thereof
10/26/2011EP2380872A1 Polycationic compounds and uses thereof
10/26/2011EP2380587A1 Use of C1 inhibitor for the prevention of ischemia-reperfusion injury
10/26/2011EP2380578A1 Bioactive agent, pharmaceutical product, cosmetic product, freshness keeping agent, and plant and animal growth promoting agent
10/26/2011EP2380562A1 A controlled-released osmotic pump tablet with lubricating layer and the preparation thereof
10/26/2011EP2380023A2 Oxidized cardiolipin as a novel pro-inflammatory factor
10/26/2011EP2379562A1 Bicyclic pyranone derivatives as nicotinic acid receptor agonists
10/26/2011EP2379542A1 Novel oxime derivatives
10/26/2011EP2379533A1 N-substituted saturated heterocyclic sulfone compounds with cb2 receptor agonistic activity
10/26/2011EP2379529A1 Novel compounds
10/26/2011EP2379492A1 Cyclohexanecarboxamide derivatives useful as inhibitors of cholesteryl ester transfer protein
10/26/2011EP2379490A1 Monohydrate of 4-({(4-carboxybutyl)[2-(2-{[4-(2-phenylethyl)benzyl]oxy}phenyl)ethyl]-amino}methyl)benzoic acid
10/26/2011EP2379489A1 Modification i of 4-({4-carboxybutyl)ý2-(2-{ý4-(2-phenylethyl)benzyl¨oxy}phenyl)ethyl¨-amino}methyl)benzoic acid
10/26/2011EP2379084A2 Modulation of factor 11 expression
10/26/2011EP2379071A2 Novel aliphatically substituted pyrazolopyridines, and the use thereof
10/26/2011EP2379054A1 Formulation for delivering lipid-lowering drugs by oral transmucosal administration
10/26/2011EP2238110B1 5.6-bisaryl-2-pyridine-carboxamide derivatives, preparation thereof and therapeutic application thereof as antagonists for urotensine ii receptors
10/26/2011EP1864994B1 Par-2 agonist
10/26/2011EP1429729B1 Combination dosage form containing a cholesterol -lowering agent , an inhibitor of the renin-angiotensin, and aspirin
10/26/2011EP1425010B1 Substituted indoles and their use as integrin antagonists
10/26/2011EP1259481B1 Substituted benzoylguanidines, method for their production, their use as a medicament or diagnostic agent and a medicament containing the same
10/26/2011CN1853673B Quality controlling method of double-Danshen injection
10/26/2011CN1813895B Chinese medicine formulation of lunar caustic for activating blood flow and removing blood stasis, and stopping pain, and its preparing method
10/26/2011CN1762967B Enoxolone derivative, preparation method and uses
10/26/2011CN102227427A Cyclobutyl purine derivative, angiogenesis promoting agent, lumenization promoting agent, neurocyte growth promoting agent, and drug
10/26/2011CN102225940A Isosorbide benzoate compound as well as preparation method and medicinal use thereof
10/26/2011CN102225929A Compound of stable Fasudil hydrochloride hydrate
1 ... 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 ... 1595